SPDL1 overexpression was associated with poor prognosis and immune status in HCC through in vitro experiment and bioinformatics analysis

Abstract Background Numerous studies have established a strong link between the overexpression of spindle apparatus coiled-coil protein 1 (SPDL1) and cancer progression. However, the role of SPDL1 in hepatocellular carcinoma (HCC) remains unconfirmed. Methods The level of SPDL1 in HCC and its potent...

Full description

Saved in:
Bibliographic Details
Main Authors: Ying-Ming Xu, Bo-Hua You, Ming Chen, Tian-Ping Xiong, Lin Shi, Qin Wei, Zhong-An Wang
Format: Article
Language:English
Published: Springer 2025-07-01
Series:Discover Oncology
Subjects:
Online Access:https://doi.org/10.1007/s12672-025-03089-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849332544968851456
author Ying-Ming Xu
Bo-Hua You
Ming Chen
Tian-Ping Xiong
Lin Shi
Qin Wei
Zhong-An Wang
author_facet Ying-Ming Xu
Bo-Hua You
Ming Chen
Tian-Ping Xiong
Lin Shi
Qin Wei
Zhong-An Wang
author_sort Ying-Ming Xu
collection DOAJ
description Abstract Background Numerous studies have established a strong link between the overexpression of spindle apparatus coiled-coil protein 1 (SPDL1) and cancer progression. However, the role of SPDL1 in hepatocellular carcinoma (HCC) remains unconfirmed. Methods The level of SPDL1 in HCC and its potential associations with prognosis and clinicopathological features were analyzed using TCGA and XENA databases. Bioinformatics and in vitro approaches were employed to investigate the biological functions, signaling pathways, and protein networks involving SPDL1. Additionally, correlation analyses were performed to explore the relationship between SPDL1 and the immune microenvironment. Results SPDL1 was overexpressed in HCC. Its overexpression correlated negatively with T stage, pathological stage, tumor status, age, body weight, differentiation, alpha-fetoprotein levels, vascular invasion, diagnosis, and poor prognosis in patients with HCC, positioning it as a risk factor for adverse outcomes. High-risk scores related to SPDL1 expression were significantly linked to poor prognosis in patients with HCC. Suppression of SPDL1 expression inhibited HCC cell proliferation, invasion, and migration. Furthermore, SPDL1 expression showed significant correlations with Th2 cells (r = 0.628), T helper cells (r = 0.296), Th17 cells (r = -0.422), neutrophils (r = -0.408), dendritic cells (r = -0.358), cytotoxic cells (r = -0.310), plasmacytoid dendritic cells (r = -0.275), and other immune cell populations in HCC. Conclusion Overexpression of SPDL1 is associated with poor prognosis and the immune microenvironment in HCC. Inhibition of SPDL1 expression can suppress tumor growth and metastasis, suggesting that SPDL1 may serve as a potential therapeutic target for HCC treatment.
format Article
id doaj-art-8e5e8c03e2ae4f3d89d86f711cb8f64d
institution Kabale University
issn 2730-6011
language English
publishDate 2025-07-01
publisher Springer
record_format Article
series Discover Oncology
spelling doaj-art-8e5e8c03e2ae4f3d89d86f711cb8f64d2025-08-20T03:46:09ZengSpringerDiscover Oncology2730-60112025-07-0116111810.1007/s12672-025-03089-8SPDL1 overexpression was associated with poor prognosis and immune status in HCC through in vitro experiment and bioinformatics analysisYing-Ming Xu0Bo-Hua You1Ming Chen2Tian-Ping Xiong3Lin Shi4Qin Wei5Zhong-An Wang6Department of Vascular interventional, Xingyi People’s HospitalDepartment of Hepatobiliary Surgery, The People’s Hospital of HonghuDepartment of Vascular interventional, Xingyi People’s HospitalDepartment of Vascular interventional, Xingyi People’s HospitalDepartment of Vascular interventional, Xingyi People’s HospitalDepartment of Vascular interventional, Xingyi People’s HospitalDepartment of Vascular interventional, Xingyi People’s HospitalAbstract Background Numerous studies have established a strong link between the overexpression of spindle apparatus coiled-coil protein 1 (SPDL1) and cancer progression. However, the role of SPDL1 in hepatocellular carcinoma (HCC) remains unconfirmed. Methods The level of SPDL1 in HCC and its potential associations with prognosis and clinicopathological features were analyzed using TCGA and XENA databases. Bioinformatics and in vitro approaches were employed to investigate the biological functions, signaling pathways, and protein networks involving SPDL1. Additionally, correlation analyses were performed to explore the relationship between SPDL1 and the immune microenvironment. Results SPDL1 was overexpressed in HCC. Its overexpression correlated negatively with T stage, pathological stage, tumor status, age, body weight, differentiation, alpha-fetoprotein levels, vascular invasion, diagnosis, and poor prognosis in patients with HCC, positioning it as a risk factor for adverse outcomes. High-risk scores related to SPDL1 expression were significantly linked to poor prognosis in patients with HCC. Suppression of SPDL1 expression inhibited HCC cell proliferation, invasion, and migration. Furthermore, SPDL1 expression showed significant correlations with Th2 cells (r = 0.628), T helper cells (r = 0.296), Th17 cells (r = -0.422), neutrophils (r = -0.408), dendritic cells (r = -0.358), cytotoxic cells (r = -0.310), plasmacytoid dendritic cells (r = -0.275), and other immune cell populations in HCC. Conclusion Overexpression of SPDL1 is associated with poor prognosis and the immune microenvironment in HCC. Inhibition of SPDL1 expression can suppress tumor growth and metastasis, suggesting that SPDL1 may serve as a potential therapeutic target for HCC treatment.https://doi.org/10.1007/s12672-025-03089-8SPDL1Hepatocellular carcinomaBiomarkersNomogramBioinformatics
spellingShingle Ying-Ming Xu
Bo-Hua You
Ming Chen
Tian-Ping Xiong
Lin Shi
Qin Wei
Zhong-An Wang
SPDL1 overexpression was associated with poor prognosis and immune status in HCC through in vitro experiment and bioinformatics analysis
Discover Oncology
SPDL1
Hepatocellular carcinoma
Biomarkers
Nomogram
Bioinformatics
title SPDL1 overexpression was associated with poor prognosis and immune status in HCC through in vitro experiment and bioinformatics analysis
title_full SPDL1 overexpression was associated with poor prognosis and immune status in HCC through in vitro experiment and bioinformatics analysis
title_fullStr SPDL1 overexpression was associated with poor prognosis and immune status in HCC through in vitro experiment and bioinformatics analysis
title_full_unstemmed SPDL1 overexpression was associated with poor prognosis and immune status in HCC through in vitro experiment and bioinformatics analysis
title_short SPDL1 overexpression was associated with poor prognosis and immune status in HCC through in vitro experiment and bioinformatics analysis
title_sort spdl1 overexpression was associated with poor prognosis and immune status in hcc through in vitro experiment and bioinformatics analysis
topic SPDL1
Hepatocellular carcinoma
Biomarkers
Nomogram
Bioinformatics
url https://doi.org/10.1007/s12672-025-03089-8
work_keys_str_mv AT yingmingxu spdl1overexpressionwasassociatedwithpoorprognosisandimmunestatusinhccthroughinvitroexperimentandbioinformaticsanalysis
AT bohuayou spdl1overexpressionwasassociatedwithpoorprognosisandimmunestatusinhccthroughinvitroexperimentandbioinformaticsanalysis
AT mingchen spdl1overexpressionwasassociatedwithpoorprognosisandimmunestatusinhccthroughinvitroexperimentandbioinformaticsanalysis
AT tianpingxiong spdl1overexpressionwasassociatedwithpoorprognosisandimmunestatusinhccthroughinvitroexperimentandbioinformaticsanalysis
AT linshi spdl1overexpressionwasassociatedwithpoorprognosisandimmunestatusinhccthroughinvitroexperimentandbioinformaticsanalysis
AT qinwei spdl1overexpressionwasassociatedwithpoorprognosisandimmunestatusinhccthroughinvitroexperimentandbioinformaticsanalysis
AT zhonganwang spdl1overexpressionwasassociatedwithpoorprognosisandimmunestatusinhccthroughinvitroexperimentandbioinformaticsanalysis